Hageman factor, platelets and polyphosphates: early history and recent connection

Summary.  Platelet activation and blood coagulation are essential for hemostasis and contribute to a variety of other biological processes such as inflammation, complement activation and tissue repair. Factor (F)XII, originally called Hageman factor, plays an important role in the kallikrein‐kinin system by activating prekallikrein. In the 1960s, a platelet activity that promoted FXII activation was identified but its biochemical nature remained unknown. Inorganic polyphosphates (poly P) are polymers that consist of many phosphate residues linked by phosphoanhydride bonds. These polymers exist in all living organisms. In bacteria, poly P is important for growth and survival. Recently, poly P has been identified in human platelet dense granules. Studied have shown that upon platelet activation and secretion, poly P activates FXII, indicating that it is most likely the elusive platelet FXII activator. Poly P also regulates coagulation and fibrinolysis. In this review, we focus on early studies of FXII and the identification of platelet FXII activation activity, and discuss recent findings of poly P in FXII activation and coagulation.

[1]  A. Gruber,et al.  Platelet polyphosphate: an endogenous activator of coagulation factor XII , 2010, Journal of thrombosis and haemostasis : JTH.

[2]  L. Leung,et al.  Polyphosphate binds with high affinity to exosite II of thrombin , 2010, Journal of thrombosis and haemostasis : JTH.

[3]  T. Renné,et al.  Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo , 2009, Cell.

[4]  A. Houng,et al.  Platelet Dense-Granule Secretion Plays a Critical Role in Thrombosis and Subsequent Vascular Remodeling in Atherosclerotic Mice , 2009, Circulation.

[5]  Arthur Kornberg,et al.  Inorganic polyphosphate: essential for growth and survival. , 2009, Annual review of biochemistry.

[6]  J. Morrissey,et al.  Polyphosphate as a general procoagulant agent , 2008, Journal of thrombosis and haemostasis : JTH.

[7]  A. Schmaier.  The elusive physiologic role of Factor XII. , 2008, The Journal of clinical investigation.

[8]  C. Maas,et al.  Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. , 2008, The Journal of clinical investigation.

[9]  K. Preissner,et al.  Factor VII-activating protease (FSAP): Vascular functions and role in atherosclerosis , 2008, Thrombosis and Haemostasis.

[10]  James H Morrissey,et al.  Polyphosphate enhances fibrin clot structure. , 2007, Blood.

[11]  J. Harper,et al.  DNA damage: ubiquitin marks the spot , 2008, Nature Structural &Molecular Biology.

[12]  A. Schmaier,et al.  The plasma kallikrein–kinin system: its evolution from contact activation , 2007, Journal of thrombosis and haemostasis : JTH.

[13]  T. Renné,et al.  Intrinsic Pathway of Coagulation and Arterial Thrombosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[14]  T. Renné,et al.  Role of Factor XII in hemostasis and thrombosis: clinical implications , 2007, Expert review of cardiovascular therapy.

[15]  R. Colman,et al.  Fifty years of research on the plasma kallikrein-kinin system: From protein structure and function to cell biology and in-vivo pathophysiology , 2007, Thrombosis and Haemostasis.

[16]  T. Renné,et al.  The intrinsic pathway of coagulation: a target for treating thromboembolic disease? , 2007, Journal of thrombosis and haemostasis : JTH.

[17]  W. Bode.  The structure of thrombin: a janus-headed proteinase. , 2006, Seminars in thrombosis and hemostasis.

[18]  James H Morrissey,et al.  Polyphosphate modulates blood coagulation and fibrinolysis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[19]  B. Furie,et al.  Thrombus formation in vivo. , 2005, The Journal of clinical investigation.

[20]  T. Renné,et al.  Defective thrombus formation in mice lacking coagulation factor XII , 2005, The Journal of experimental medicine.

[21]  E. Oldfield,et al.  Human Platelet Dense Granules Contain Polyphosphate and Are Similar to Acidocalcisomes of Bacteria and Unicellular Eukaryotes* , 2004, Journal of Biological Chemistry.

[22]  N. Mackman.  Role of tissue factor in hemostasis, thrombosis, and vascular development. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[23]  J. Morrissey.  Tissue factor: A key molecule in hemostatic and nonhemostatic systems , 2004, International journal of hematology.

[24]  E. Davie,et al.  A Brief Historical Review of the Waterfall/Cascade of Blood Coagulation , 2003, Journal of Biological Chemistry.

[25]  H. Roberts,et al.  Oscar ratnoff: his contributions to the golden era of coagulation research , 2003, British journal of haematology.

[26]  S. Iwanaga.  The molecular basis of innate immunity in the horseshoe crab. , 2002, Current opinion in immunology.

[27]  S. J. Degen,et al.  GENE TARGETING IN HEMOSTASIS , 2002 .

[28]  A Kornberg,et al.  Role of Inorganic Polyphosphate in Promoting Ribosomal Protein Degradation by the Lon Protease in E. coli , 2001, Science.

[29]  Q. Wu.  Gene targeting in hemostasis. Hepsin. , 2001, Frontiers in bioscience : a journal and virtual library.

[30]  J. Spivak,et al.  Commentary on and reprint of Davie EW, Ratnoff OD, Waterfall sequence for intrinsic blood clotting, in Science (1964) 145:1310–1311 , 2000 .

[31]  T. Kulakovskaya,et al.  Polyphosphate and phosphate pump. , 2000, Annual review of microbiology.

[32]  J. Römisch,et al.  A protease isolated from human plasma activating factor VII independent of tissue factor. , 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[33]  B. Lämmle,et al.  Reevaluation of the Incidence of Thromboembolic Complications in Congenital Factor XII Deficiency , 1999, Thrombosis and Haemostasis.

[34]  M. Halks-Miller,et al.  Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease. , 1998, The Journal of clinical investigation.

[35]  C. Gibbs,et al.  Modulation of Thrombin’s Procoagulant and Anticoagulant Properties , 1997, Thrombosis and Haemostasis.

[36]  S. Iwanaga,et al.  The role of hemolymph coagulation in innate immunity. , 1996, Current opinion in immunology.

[37]  P. A. von dem Borne,et al.  Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. , 1995, Blood.

[38]  A. Kornberg,et al.  Inorganic Polyphosphate in Mammalian Cells and Tissues (*) , 1995, The Journal of Biological Chemistry.

[39]  A. Kornberg.  Inorganic polyphosphate: toward making a forgotten polymer unforgettable , 1995, Journal of bacteriology.

[40]  W. Kisiel,et al.  Hepsin, a Putative Membrane-associated Serine Protease, Activates Human Factor VII and Initiates a Pathway of Blood Coagulation on the Cell Surface Leading to Thrombin Formation (*) , 1995, The Journal of Biological Chemistry.

[41]  G. Broze,et al.  Tissue factor pathway inhibitor and the revised theory of coagulation. , 1995, Annual review of medicine.

[42]  C. Esmon,et al.  Glycosaminoglycan contributions to both protein C activation and thrombin inhibition involve a common arginine-rich site in thrombin that includes residues arginine 93, 97, and 101. , 1994, The Journal of biological chemistry.

[43]  J. Sheehan,et al.  Molecular mapping of the heparin-binding exosite of thrombin. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Vandenbroucke,et al.  John Hageman's factor and deep‐vein thrombosis: Leiden Thrombophilia Study , 1994, British journal of haematology.

[45]  M. Aiach,et al.  Activation-induced exposure of the thrombin anion-binding exosite. Interactions of recombinant mutant prothrombins with thrombomodulin and a thrombin exosite-specific antibody. , 1994, The Journal of biological chemistry.

[46]  A. Kornberg.  ATP and inorganic pyro‐ and polyphosphate , 1993, Protein science : a publication of the Protein Society.

[47]  J. Sadler,et al.  Localization of the single-stranded DNA binding site in the thrombin anion-binding exosite. , 1992, The Journal of biological chemistry.

[48]  R. Pisoni,et al.  Incorporation of [32P]orthophosphate into long chains of inorganic polyphosphate within lysosomes of human fibroblasts. , 1992, The Journal of biological chemistry.

[49]  K Fujikawa,et al.  The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.

[50]  G. Broze,et al.  Factor XI activation in a revised model of blood coagulation , 1991, Science.

[51]  J. Sheehan,et al.  Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[52]  K Fujikawa,et al.  Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. , 1991, The Journal of biological chemistry.

[53]  P. Walsh.  Platelet-Mediated Trigger Mechanisms in the Contact Phase of Blood Coagulation , 1987, Seminars in thrombosis and hemostasis.

[54]  R. Od.  The George M. Kober lecture. The legacy of John Hageman: new dividends. , 1985 .

[55]  O. D. Ratnoff.  The George M. Kober lecture. The legacy of John Hageman: new dividends. , 1985, Transactions of the Association of American Physicians.

[56]  J. Griffin,et al.  Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI. , 1981, Blood.

[57]  O. Ratnoff,et al.  A Quarter Century with Mr. Hageman , 1980, Thrombosis and Haemostasis.

[58]  J. Miletich,et al.  Relationships between platelets and coagulation factors in hemostasis. , 1978, Annual review of medicine.

[59]  P. Walsh.  Platelet coagulant activities and hemostasis: a hypothesis. , 1974, Blood.

[60]  R. Sheon,et al.  The Demise of John Hageman , 1968 .

[61]  F. Harold.  Inorganic polyphosphates in biology: structure, metabolism, and function , 1966, Bacteriological reviews.

[62]  J. Caen,et al.  Availability of Platelet Factor 3 and Activation of Factor XII in Thrombasthenia , 1965, Nature.

[63]  R. Hutton,et al.  The Kaolin Clotting Time of Platelet‐Rich Plasma: A Test of Platelet Factor‐3 Availability , 1965, British journal of haematology.

[64]  T. Spaet,et al.  Studies on Platelet Factor‐3 Availability , 1965, British journal of haematology.

[65]  E. Davie,et al.  Waterfall Sequence for Intrinsic Blood Clotting , 1964, Science.

[66]  R. Hutton,et al.  THROMBASTHENIA. STUDIES ON THREE CASES. , 1964, British journal of haematology.

[67]  Macfarlane Rg,et al.  AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER , 1964 .

[68]  R. Macfarlane.  An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier , 1964, Nature.

[69]  E. Davie,et al.  The purification of activated Hageman factor (activated factor XII). , 1962, Biochemistry.

[70]  O. Ratnoff,et al.  Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. , 1961, The Journal of clinical investigation.

[71]  I. Wright.  Concerning the functions and nomenclature of blood clotting factors, with a preliminary report of the profile of blood clotting factors in young males. , 1959, Annals of internal medicine.

[72]  O D RATNOFF,et al.  Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition. , 1958, The American journal of medicine.

[73]  R. Biggs,et al.  Defects in the Early Stages of Blood Coagulation: A Report of Four Cases , 1958, British journal of haematology.

[74]  J. Caen,et al.  Deficit en facteur Hageman. , 1958 .

[75]  A. Kornberg,et al.  Metaphosphate synthesis by an enzyme from Escherichia coli. , 1956, Biochimica et biophysica acta.

[76]  O. Ratnoff,et al.  A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. , 1955, The Journal of clinical investigation.